Cardiovascular Risk Clinic
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Cardiovascular Disease
- Sponsor
- Windber Research Institute
- Enrollment
- 207
- Locations
- 1
- Primary Endpoint
- Body Mass Index
- Status
- Terminated
- Last Updated
- 11 years ago
Overview
Brief Summary
This study was a prospective, randomized trial designed to investigate the efficacy of moderate lifestyle modification for improving the clinical status of patients with coronary artery disease or patients with risk factors that promote coronary artery disease.
Detailed Description
The main hypothesis to be tested in the Cardiovascular Risk Clinic was: Can individualized therapeutic lifestyle plans in conjunction with molecular analysis lead to informative assessments of disease risk that can reduce risk factors for diabetes and cardiovascular disease. Our main objectives were: A. To investigate the effect of lifestyle modification on: (1) physiological measurements of coronary artery disease (CAD) including carotid intima-media thickness (CIMT), exercise stress tests, blood pressure, body mass index (BMI), and weight; (2) plasma markers associated with development of CAD such as lipids and triglycerides; and (3) molecular characteristics such as gene expression signatures and protein profiles. B. To determine if patients with heart disease or risk factors that would promote heart disease can achieve and adhere to the goals of a lifestyle change program in a non-residential, out-patient setting.
Investigators
Eligibility Criteria
Inclusion Criteria
- •at least one known risk factor for cardiovascular disease:
- •Family history of CAD (first degree relative)
- •Physician-diagnosed diabetes or stroke
- •Overweight (BMI/=25) or obese (BMI\>/=30)
- •Total cholesterol \>/=200, documented history of hypercholesterolemia, or currently taking lipid lowering medications
- •History of smoking
- •HDL \</=44 mg/dl
- •LDL \>/=130 mg/dl or documented history of hyperlipidemia
- •Elevated triglycerides (\>/=200 mg/dl)
- •Hypertension (systolic blood pressure \>/=130 mmHg, diastolic blood pressure \>/=85 mmHg, documented diagnosis of hypertension, or currently taking antihypertensive medications)
Exclusion Criteria
- •Age \<18 years of age
- •Unstable coronary syndromes, refractory congestive heart failure, uncontrolled arrhythmia, or high-grade uncorrected cardiac conduction abnormalities
- •Any contraindication to components to Program, such as physical disabilities precluding stretching and aerobic exercise or medical conditions that preclude consumption of foods essential to Program diet
- •Inability or unwillingness to give consent
- •Significant left main stenosis (\>50%) or ejection fraction \<35% with no revascularization
- •History of substance abuse (including alcohol) without self-certification of abstinence for at least three months
- •Non-ambulatory (bedridden) individuals
Outcomes
Primary Outcomes
Body Mass Index
Time Frame: Baseline, 4-6 months, 1 year, 18 months, 2 years, 30 months, 3 years
Change in BMI
Secondary Outcomes
- Blood Pressure(Baseline, 4-6 months, 1 year, 18 months, 2 years, 30 months, 3 years)
- Blood Lipids(Baseline, 4-6 months, 1 year, 18 months, 2 years, 30 months, 3 years)